Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph phase_3
2
50%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution2 total trials
Phase 3Large-scale testing
2(100.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completed

Gelatines in Pediatric PatientS

NCT02495285
completed

Volume Kinetics of Gelofusine 4% During Vascular Surgery

NCT06474052
completedphase_3

Study on the Efficacy and Safety of Gelaspan

NCT02808325
completedphase_3

Comparison of Two Gelatine Solutions

NCT01515397

Clinical Trials (4)

Showing 4 of 4 trials
NCT02495285

Gelatines in Pediatric PatientS

Completed
NCT06474052

Volume Kinetics of Gelofusine 4% During Vascular Surgery

Completed
NCT02808325Phase 3

Study on the Efficacy and Safety of Gelaspan

Completed
NCT01515397Phase 3

Comparison of Two Gelatine Solutions

Completed

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4